Ricola announces its record-breaking year 2023

 

These satisfying results were achieved in challenging market circumstances. According to the press release, every region made a substantial contribution to the good results. Both North America as well as Europe and Asia showed positive market trends. Europe makes up more than 50% of global sales growth.

Germany remains Ricola’s largest sales market in Europe. Its leading position in the cough-drop segment continued to expand thanks to the strategic reorientation of pharmacy distribution channels and a strong product launch (Ricola Raspberry Lemon Balm). Ricola also saw positive developments in other European countries. In Switzerland, Ricola’s home market, the Ricola Experience Shop was recently opened in the city of Laufen to enhance the brand.

Ricola is now the market leader in the U.S. cough-drop segment. This positive growth was a result of two new strong products (Ricola Throat Balm and Ricola Cherry) as well as successful advertising campaigns. In Canada, the brand also saw growth and continued to increase its share. The U.S. has now become Ricola’s largest market, and Canada is also one of its top markets.

Ricola has seen successful numbers in Asia for many decades now. Last year, the Ricola Group also increased its share of the Asian markets and reached double-digit sales growth for the second year in a row. In some Asian markets, new distribution partners were contracted, laying the foundation for sustainable, healthy business growth. In the growing markets of China and Korea, local advertising with Asian superstar Cha Eun-woo successfully captured consumers’ attention.